REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. read more

EMPLOYEE PARTICIPANTS: 10

TOTAL RATINGS: 199

CEO: Ken Mills

REGENXBIO Executive Team

The REGENXBIO Executive Team is rated a "D+" and led by CEO Ken Mills. REGENXBIO employees rate their Executive Team in the Bottom 25% of similar size companies on Comparably with 1-10 Employees.

Out of their 3 competitors, Intellia Therapeutics, Dimension Therapeutics, and Kadmon, REGENXBIO's score ranks in 2nd place.

Last updated months ago.

Where This Score Ranks REGENXBIO's Executive Team

BOTTOM
25%
In the Bottom 25% of 1750 Similar Sized Companies on Comparably
BOTTOM
30%
In the Bottom 30% of 177 Nearby Companies in Washington, DC
2nd
2nd place versus 3 competitors rated on Comparably

Nov

Mar

Jan

Feb

D+61 / 100

Jan

REGENXBIO Key Executives

Name & Title

Bio

Who Ranks REGENXBIO's Executive Team the Highest?

Not Enough Ratings To Show Who Ranks Executive Team the Highest

Anonymously rate my experience at REGENXBIO

Who Ranks REGENXBIO's Executive Team the Lowest?

Not Enough Ratings To Show Who Ranks Executive Team the Lowest

Anonymously rate my experience at REGENXBIO

REGENXBIO's Executive Team Trendline

REGENXBIO60
Other Companies in Washington, DC
Similar Size on Comparably

REGENXBIO Executive Team At a Glance

The Executive Team Score of 61/100 is calculated by combining aggregate responses to the questions of “How would you rate your executive team?” and “Do you approve of the job your executive team is doing at your company?”

50% of employees say “Yes, they approve of the job the executive team is doing at REGENXBIO.”

The last rating scoring REGENXBIO's executive team was provided months ago and has remained stable at 61 over the last 90 days.